SOTAC PHARMACEUTICALS
Back to Balance Sheet
|
SOTAC PHARMACEUTICALS Last 5 Year Total Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Liabilities | ₹123 Cr | ₹104 Cr | ₹74 Cr | ₹35 Cr | ₹35 Cr |
What is the latest Total Liabilities ratio of SOTAC PHARMACEUTICALS ?
| Year | Total Liabilities |
|---|---|
| Mar2025 | ₹123 Cr |
| Mar2024 | ₹104 Cr |
| Mar2023 | ₹74 Cr |
| Mar2022 | ₹35 Cr |
| Mar2021 | ₹35 Cr |
How is Total Liabilities of SOTAC PHARMACEUTICALS Trending?
| Years | Total Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹123 Cr | 18.41 | |
| Mar2024 | ₹104 Cr | 41.09 | |
| Mar2023 | ₹74 Cr | 109.01 | |
| Mar2022 | ₹35 Cr | 1.54 | |
| Mar2021 | ₹35 Cr | - | |
Compare Total Liabilities of peers of SOTAC PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| SOTAC PHARMACEUTICALS | ₹97.0 Cr | -12.6% | -21.4% | -24% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹455,394.0 Cr | -2.3% | -3.3% | 15.7% | Stock Analytics | |
| DIVIS LABORATORIES | ₹227,958.0 Cr | 0.3% | 16.3% | 44.3% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹190,678.0 Cr | 2.8% | -0.5% | 37.1% | Stock Analytics | |
| CIPLA | ₹116,141.0 Cr | -3.1% | -1.2% | -5.8% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹98,604.4 Cr | -2.9% | -3% | -3.3% | Stock Analytics | |
SOTAC PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| SOTAC PHARMACEUTICALS | -12.6% |
-21.4% |
-24% |
| SENSEX | -1.4% |
-1% |
-4.6% |
You may also like the below Video Courses